Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.
Xin-Lin ChenYu-Mei WangFei ZhaoZheng ChenXiaofei YangCong SunYunpeng GaoTian-Ge YangGuo TianYi-Ming ChenShui-Lian ZhuXiao-Bing LinFeng-Bin LiuPublished in: The journal of gene medicine (2019)
The MTHFR rs1801133 polymorphism was not associated with the prognosis of patients with CRC; however, rs1801131 may be associated with the prognosis of patients with CRC. Well-designed prospective studies are necessary to obtain a better understanding of the prognostic value of rs1801133 and rs1801131.
Keyphrases